Frontlight ResearchEarly access
Type 2 diabetes trials in Croatia
5 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Cepin, Grad Zagreb, Krapinske Toplice, Opatija, Osijek, Rijeka
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Grad Zagreb, Karlovac, Krapinske Toplice, Osijek, Rijeka, Slavonski Brod, Solin
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - Phase 3Taking peopleA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Grad Zagreb, Osijek, Pula - Pola, Rijeka, Varazdin
- Age
- 18 years and over
- People
- 1,060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - Phase 2Active, not recruitingA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Grad Zagreb, Karlovac, Osijek, Varazdin
- Age
- 18 years to 75 years
- People
- 270 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00 - No phaseTaking peopleRemission of Type 2 Diabetes With Lifestyle Intervention
- Where
- Split
- Age
- 20 years to 69 years
- People
- 120
- Run by
- University of Split, School of Medicine
See details and how to joinNCT07017127